A.J. Rice
Stock Analyst at UBS
(4.17)
# 430
Out of 5,124 analysts
262
Total ratings
61.85%
Success rate
9.93%
Average return
Main Sectors:
Stocks Rated by A.J. Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Buy | $430 → $410 | $276.65 | +48.20% | 13 | Jan 28, 2026 | |
| AVAH Aveanna Healthcare Holdings | Maintains: Neutral | $9.5 → $10 | $7.85 | +27.39% | 13 | Jan 15, 2026 | |
| EHAB Enhabit | Upgrades: Buy | $8.5 → $12 | $11.13 | +7.82% | 4 | Jan 8, 2026 | |
| ARDT Ardent Health | Maintains: Buy | $15 → $14 | $8.94 | +56.60% | 2 | Dec 18, 2025 | |
| PACS PACS Group | Reinstates: Buy | $50 → $42 | $38.68 | +8.58% | 2 | Dec 18, 2025 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $17 → $9 | $8.69 | +3.57% | 10 | Dec 9, 2025 | |
| SGRY Surgery Partners | Maintains: Buy | $34 → $29 | $13.56 | +113.86% | 2 | Nov 13, 2025 | |
| AMN AMN Healthcare Services | Maintains: Neutral | $18 → $21 | $20.30 | +0.99% | 11 | Nov 7, 2025 | |
| ENSG The Ensign Group | Maintains: Buy | $205 → $220 | $197.80 | +11.22% | 4 | Nov 5, 2025 | |
| MD Pediatrix Medical Group | Maintains: Neutral | $17 → $23 | $20.89 | +10.10% | 19 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $31 → $42 | $38.46 | +9.20% | 20 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $238 → $260 | $201.37 | +29.12% | 12 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $302 | $218.56 | +38.18% | 17 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $42 | $39.68 | +5.85% | 6 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $22 | $19.40 | +13.40% | 12 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.2 → $3.6 | $3.15 | +14.29% | 8 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $95 | $85.11 | +11.62% | 13 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $150 | $105.39 | +42.33% | 9 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $435 → $425 | $338.98 | +25.38% | 5 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $145 | $105.88 | +36.95% | 1 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $14 | $15.69 | -10.77% | 8 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $68 | $64.72 | +5.07% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $38 → $40 | $34.01 | +17.63% | 2 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $450 → $485 | $948.68 | -48.88% | 1 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $95 | $13.37 | +610.55% | 13 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $311 → $316 | $501.69 | -37.01% | 12 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $96 | $78.35 | +22.53% | 6 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $635 → $575 | $193.94 | +196.48% | 9 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $308 → $305 | $277.20 | +10.03% | 4 | Nov 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $64 → $79 | $226.32 | -65.09% | 3 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $350 → $410 | $131.72 | +211.27% | 3 | Oct 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $158 → $143 | $190.71 | -25.02% | 9 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $270 | $292.05 | -7.55% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $0.57 | $24.25 | -97.65% | 3 | Jan 25, 2021 |
UnitedHealth Group
Jan 28, 2026
Maintains: Buy
Price Target: $430 → $410
Current: $276.65
Upside: +48.20%
Aveanna Healthcare Holdings
Jan 15, 2026
Maintains: Neutral
Price Target: $9.5 → $10
Current: $7.85
Upside: +27.39%
Enhabit
Jan 8, 2026
Upgrades: Buy
Price Target: $8.5 → $12
Current: $11.13
Upside: +7.82%
Ardent Health
Dec 18, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $8.94
Upside: +56.60%
PACS Group
Dec 18, 2025
Reinstates: Buy
Price Target: $50 → $42
Current: $38.68
Upside: +8.58%
Cross Country Healthcare
Dec 9, 2025
Maintains: Neutral
Price Target: $17 → $9
Current: $8.69
Upside: +3.57%
Surgery Partners
Nov 13, 2025
Maintains: Buy
Price Target: $34 → $29
Current: $13.56
Upside: +113.86%
AMN Healthcare Services
Nov 7, 2025
Maintains: Neutral
Price Target: $18 → $21
Current: $20.30
Upside: +0.99%
The Ensign Group
Nov 5, 2025
Maintains: Buy
Price Target: $205 → $220
Current: $197.80
Upside: +11.22%
Pediatrix Medical Group
Nov 5, 2025
Maintains: Neutral
Price Target: $17 → $23
Current: $20.89
Upside: +10.10%
Oct 30, 2025
Maintains: Neutral
Price Target: $31 → $42
Current: $38.46
Upside: +9.20%
Oct 29, 2025
Maintains: Buy
Price Target: $238 → $260
Current: $201.37
Upside: +29.12%
Oct 29, 2025
Maintains: Buy
Price Target: $280 → $302
Current: $218.56
Upside: +38.18%
Oct 29, 2025
Maintains: Buy
Price Target: $35 → $42
Current: $39.68
Upside: +5.85%
Oct 28, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $19.40
Upside: +13.40%
Oct 27, 2025
Maintains: Neutral
Price Target: $3.2 → $3.6
Current: $3.15
Upside: +14.29%
Oct 13, 2025
Maintains: Buy
Price Target: $88 → $95
Current: $85.11
Upside: +11.62%
Oct 2, 2025
Maintains: Buy
Price Target: $140 → $150
Current: $105.39
Upside: +42.33%
Sep 5, 2025
Maintains: Buy
Price Target: $435 → $425
Current: $338.98
Upside: +25.38%
Sep 2, 2025
Initiates: Buy
Price Target: $145
Current: $105.88
Upside: +36.95%
Aug 4, 2025
Maintains: Neutral
Price Target: $15 → $14
Current: $15.69
Upside: -10.77%
May 5, 2025
Maintains: Neutral
Price Target: $80 → $68
Current: $64.72
Upside: +5.07%
Apr 30, 2025
Upgrades: Buy
Price Target: $38 → $40
Current: $34.01
Upside: +17.63%
Aug 11, 2023
Maintains: Outperform
Price Target: $450 → $485
Current: $948.68
Upside: -48.88%
Jul 31, 2023
Reiterates: Outperform
Price Target: $95
Current: $13.37
Upside: +610.55%
Jul 28, 2023
Maintains: Outperform
Price Target: $311 → $316
Current: $501.69
Upside: -37.01%
May 8, 2023
Maintains: Outperform
Price Target: $125 → $96
Current: $78.35
Upside: +22.53%
Feb 6, 2023
Maintains: Outperform
Price Target: $635 → $575
Current: $193.94
Upside: +196.48%
Nov 23, 2022
Maintains: Outperform
Price Target: $308 → $305
Current: $277.20
Upside: +10.03%
Nov 22, 2022
Maintains: Neutral
Price Target: $64 → $79
Current: $226.32
Upside: -65.09%
Oct 27, 2022
Maintains: Outperform
Price Target: $350 → $410
Current: $131.72
Upside: +211.27%
Jul 22, 2022
Maintains: Neutral
Price Target: $158 → $143
Current: $190.71
Upside: -25.02%
Aug 6, 2021
Maintains: Outperform
Price Target: $300 → $270
Current: $292.05
Upside: -7.55%
Jan 25, 2021
Downgrades: Underperform
Price Target: $0.57
Current: $24.25
Upside: -97.65%